Switch from anakinra to canakinumab in a severe case of CINCA syndrome

Donato Rigante; Elena Verrecchia; Benedetto Falsini; Raffaele Manna

doi:10.1111/1756-185X.12800

Switch from anakinra to canakinumab in a severe case of CINCA syndrome

Donato Rigante
, Elena Verrecchia
, Benedetto Falsini
, Raffaele Manna

Risultato della ricerca: Contributo in rivista › Articolo › peer review

4 Citazioni (Scopus)

Abstract

A boy with CINCA syndrome is reported, focusing on the therapeutic switch from anakinra to canakinumab.

Lingua originale	Inglese
pagine (da-a)	1354-1356
Rivista	International Journal of Rheumatic Diseases
Volume	19
DOI	https://doi.org/10.1111/1756-185X.12800
Stato di pubblicazione	Pubblicato - 2016

Keywords

CINCA syndrome
Canakinumab

Accesso al documento

10.1111/1756-185X.12800

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{eb2a9a37ca694f3aa69735266895a519,

title = "Switch from anakinra to canakinumab in a severe case of CINCA syndrome",

abstract = "A boy with CINCA syndrome is reported, focusing on the therapeutic switch from anakinra to canakinumab.",

keywords = "CINCA syndrome, Canakinumab, CINCA syndrome, Canakinumab",

author = "Donato Rigante and Elena Verrecchia and Benedetto Falsini and Raffaele Manna",

year = "2016",

doi = "10.1111/1756-185X.12800",

language = "English",

volume = "19",

pages = "1354--1356",

journal = "International Journal of Rheumatic Diseases",

issn = "1756-1841",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Switch from anakinra to canakinumab in a severe case of CINCA syndrome

AU - Rigante, Donato

AU - Verrecchia, Elena

AU - Falsini, Benedetto

AU - Manna, Raffaele

PY - 2016

Y1 - 2016

N2 - A boy with CINCA syndrome is reported, focusing on the therapeutic switch from anakinra to canakinumab.

AB - A boy with CINCA syndrome is reported, focusing on the therapeutic switch from anakinra to canakinumab.

KW - CINCA syndrome

KW - Canakinumab

KW - CINCA syndrome

KW - Canakinumab

UR - http://hdl.handle.net/10807/68758

U2 - 10.1111/1756-185X.12800

DO - 10.1111/1756-185X.12800

M3 - Article

SN - 1756-1841

VL - 19

SP - 1354

EP - 1356

JO - International Journal of Rheumatic Diseases

JF - International Journal of Rheumatic Diseases

ER -

Switch from anakinra to canakinumab in a severe case of CINCA syndrome

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo